Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 3
A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with sever…
Lower Respiratory Tract InfectionParainfluenzaImmunocompromised+1 more
Ansun Biopharma, Inc.NCT03808922
Observational
A Pivotal, Single Arm, Open Label Clinical Study to Assess the Safety and Efficacy of Intratumoral Alpha DaRT224 for the Treatment of Immunocompromised Patients With Cutaneous Squamous Cell Carcinoma
This is a multi-center clinical study enrolling up to 28 participants. The primary objectives are to determine the objective response rate (ORR) established by…
Squamous Cell CarcinomaAlpha RadiationImmunocompromised+3 more
Alpha Tau Medical LTD.NCT06615635
Phase 1
Administration of Off-the-Shelf, Expanded, Most Closely HLA Matched, Third Party Adenovirus Specific T Cells for Therapy of Adenovirus Related Disease in Immunocompromised Patients
This phase I trial studies the side effects of allogeneic adenovirus-specific cytotoxic T lymphocytes (donor T cell therapy) and to see how well they work in t…
Hematopoietic and Lymphoid Cell NeoplasmImmunocompromised
M.D. Anderson Cancer CenterNCT03425526
Phase 2
Third Party Viral Specific T-cells (VSTs) for Treatment of Viral Infections in Immunocompromised Patients
The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely …
Viral InfectionViral ReactivationInfection in an Immunocompromised Host
Children's Hospital Medical Center, CincinnatiNCT02532452